Glaukos GKOS
NYSE GKOS
$188.33 -1.22 (-0.64%)
At close: Aug 20, 2026 · 1:15 PM UTC

Glaukos (GKOS) Liabilities and Shareholders Equity (2014 - 2026)

Glaukos (GKOS) posted quarterly Liabilities and Shareholders Equity of $920.5 million for Q2 2026, down 6.73% year-over-year from $987.0 million in Q2 2025, and up 3.04% quarter-over-quarter from $893.3 million in Q1 2026.

Glaukos (GKOS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has reported Liabilities and Shareholders Equity for 13 consecutive years, with $920.5 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity fell 6.73% year-over-year to $920.5 million; the TTM figure through Jun 2026 stood at $3.7 billion (down 3.83% YoY), while the FY2025 annual figure was $893.5 million, down 8.34% from the prior year.
  • Liabilities and Shareholders Equity improved to $920.5 million in Q2 2026 per GKOS's latest filing, from $893.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.1 billion in Q1 2022 and bottomed at $893.3 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $962.6 million across 5 years, with a median of $961.5 million in 2023.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 7.86% in 2025 and fell as far as 8.34% in 2025.
  • Glaukos' Liabilities and Shareholders Equity stood at $1.0 billion in 2022, then retreated by 6.18% to $940.4 million in 2023, then climbed by 3.65% to $974.8 million in 2024, then slipped by 8.34% to $893.5 million in 2025, then advanced by 3.03% to $920.5 million in 2026.
  • Business Quant data shows GKOS's Liabilities and Shareholders Equity at $920.5 million in Q2 2026, $893.3 million in Q1 2026, and $893.5 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 199.24 Bn 193.64 Bn 7.27 Bn 109.22 Bn
2 Stryker 128.63 Bn 125.15 Bn 4.50 Bn 47.93 Bn
3 Medtronic 119.19 Bn 109.97 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.51 Bn 72.97 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 52.11 Bn 47.85 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 34.01 Bn 31.90 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.40 Bn 23.08 Bn 4.55 Bn 31.04 Bn
9 Steris 23.14 Bn 22.65 Bn 684.20 Mn 10.74 Bn
10 Glaukos 11.08 Bn 10.96 Bn 151.59 Mn 920.52 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 920.52 Mn
Mar 31, 2026 893.33 Mn
Dec 31, 2025 893.49 Mn
Sep 30, 2025 999.38 Mn
Jun 30, 2025 986.96 Mn
Mar 31, 2025 966.18 Mn
Dec 31, 2024 974.76 Mn
Sep 30, 2024 926.54 Mn
Jun 30, 2024 919.68 Mn
Mar 31, 2024 933.34 Mn
Dec 31, 2023 940.41 Mn
Sep 30, 2023 948.63 Mn
Jun 30, 2023 956.74 Mn
Mar 31, 2023 972.59 Mn
Dec 31, 2022 1.00 Bn
Sep 30, 2022 1.01 Bn
Jun 30, 2022 1.03 Bn
Mar 31, 2022 1.05 Bn
Dec 31, 2021 1.05 Bn
Sep 30, 2021 1.06 Bn